Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Stomach Neoplasms × folfirinox × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 33 Neoplasms 5 Colorectal Neoplasms 4 Adenocarcinoma 3 Resectable Pancreatic Cancer 2 Rectal Neoplasms 2 Pancreatic Cancer Metastatic 2 Neoplasm Metastasis 2 Carcinoma, Hepatocellular 2 Urachal cancer 1 Stomach Neoplasms 1 Pancreatic Adenocarcinoma 1 Neoplasms, Basal Cell 1 Locally Advanced Unresectable or Metastatic Solid Tumors 1 Locally Advanced Pancreatic Adenocarcinoma 1 Localized Pancreatic Adenocarcinoma 1 Gastrointestinal Neoplasms 1 Gastroesophageal Adenocarcinoma 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Cancer Metastatic 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Pancreatic Ductal 1 Carcinoma 1 Borderline Resectable Pancreatic Cancer 1 Biliary Tract Neoplasms 1 Ampullary Adenocarcinoma 1

Interventions

Oxaliplatin 252 Capecitabine 175 Fluorouracil 162 Cisplatin 139 Docetaxel 120 S 1 (combination) 115 Leucovorin 108 Paclitaxel 107 Irinotecan 97 pembrolizumab 80 Trastuzumab 57 apatinib 54 Nivolumab 47 Drug Therapy 46 Surgical Procedures, Operative 38 sintilimab 36 Radiotherapy 36 Ramucirumab 34 Bevacizumab 34 tislelizumab 29 Hyperthermic Intraperitoneal Chemotherapy 29 Epirubicin 29 titanium silicide 26 Carboplatin 26 XELOX 24 Gastrectomy 24 Cyclophosphamide 24 Folfox protocol 20 Tegafur 19 Cetuximab 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03825861 2020-11-10

FOLFIRINOX

Instituto do Cancer do Estado de São Paulo

Phase 2 Recruiting

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡